A research team at the Royal National ENT and Eastman Dental Hospitals have won an award for their outstanding contribution to the NIHR portfolio of studies.
More research is needed to find the best ways of identifying the underlying causes and combatting the growing threat of antimicrobial resistance (AMR) around the world, according to a comment article published this week in The Lancet.
UCLH and UCL clinicians and academics have been named among the ‘world’s most influential researchers.’
UCLH is to trial a set of interventions to improve hospital care for people who use opioids such as heroin.
Research has found that patients who get their chest X-ray results immediately are diagnosed in half the usual time.
3000 participants have been recruited to a trial aimed at reducing the number of patients with breast cancer who are given chemotherapy unnecessarily.
Research concludes that regularly monitoring women who carry BRCA gene alterations is beneficial.
Problematic alcohol use is associated with increased odds of suicide or self-harm, according to a study led by UCL.
UCLH will play a vital role in a new respiratory virus study.
People taking part in research at UCLH feel valued and have a positive experience while on a study, according to results of a national survey.
UCLH consultant Professor Sir Alimuddin Zumla has been awarded a prestigious medal for his work over decades across a range of communicable diseases.
UCLH is to host to a new collaboration researching patient safety, after being awarded £3million in funding from the NIHR.
The substantial weight loss and improved cardiometabolic health achieved by people given an exciting new drug to treat obesity is maintained if people continue to take the mediation.
Our NIHR BRC has been awarded over £90million
Researchers are to trial a new weight loss treatment which involves reducing blood supply to part of the stomach.